Modeling Center of Excellence Practices to Improve the Care of Patients With Biomarker-Driven Thyroid Cancer or Non-Small-Cell Lung Cancer

Biomarker testing is key to unlocking the potential of precision medicine. Are your molecular testing procedures optimized to guide treatment for your patients with advanced NSCLC or thyroid cancer?
 
Assess your current practices, review the latest evidence and best practices shared by leaders in the field, and create a plan to optimize testing and treatment selection practices to ensure your patients are benefitting from the latest advancements in biomarker testing and precision medicine.  Different education pathways are available for thyroid cancer, NSCLC, and a focus on molecular pathology in both tumor types. Use these materials on your own or to facilitate scenario-based learning and action planning with your team to improve biomarker testing practices.
 
Educational Partner: The Academy for Continued Healthcare Learning (ACHL)

Medium: Online Presentation

Commercial Support: Support for this activity has been provided through an educational grant from Lilly.

Target Audience

This activity is intended for oncologists, pathologists and the multidisciplinary team practicing in academic and community settings who treat patients with NSCLC or thyroid cancer.

Learning Objectives

At the conclusion of this activity, participants will be able to:

  • Develop improved models for early and effective biomarker testing
  • Identify appropriate patients and optimize treatment for RET-targeted therapy
  • Develop strategies to mitigate challenges and barriers to optimizing RET testing for patients with NSCLC and thyroid cancer
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
For more information, please contact:
CME Coordinator Contact Name: 
Karen Catino
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
877-444-8435 ext. 160
Summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Activity opens: 
01/31/2024
Activity expires: 
01/31/2025
FACULTY
  Maria Arcila, MD
  Attending Pathologist and Laboratory Director, Diagnostic Molecular Pathology
  Medical Director, Molecular Hematopathology
  Memorial Sloan Kettering Cancer Center
  New York, NY

 
  Marcia Brose, MD, PhD, FASCO
  Director, Cancer Services
  Vice Chair, Hematology and Medical Oncology
  Co-Director Community Based Clinical Trials
  Sidney Kimmel Cancer Center - Jefferson Health
  Philadelphia, PA

 
  Lori Wirth, MD
  Associate Professor
  Harvard Medical School
  Medical Director
  Massachusetts General Hospital’s Center for Head and Neck Cancers
  Boston, MA
 

 
REVIEWER
  Christine Bestvina, MD
  Associate Professor
  Department of Medicine, Section of Hematology/Oncology
  University of Chicago Medicine
  Chicago, IL
 
 
 

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
The University Of Chicago Pritzker School Of Medicine designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
 
Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.
Registration: To view this activity, you will need to visit ACHL's website.
Click here to view the activity, or if you are logged in, click on the "Complete Activity" button!
 
Please login or create an account to proceed.